Related Experiment Video
Updated: Jun 3, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
A cathelicidin-2-derived peptide effectively impairs Staphylococcus epidermidis biofilms
E Margo Molhoek1, Albert van Dijk, Edwin J A Veldhuizen
1TNO Defense, Security and Safety, Rijswijk, The Netherlands.
The novel peptide F(2,5,12)W effectively prevents Staphylococcus epidermidis biofilm formation and disrupts existing biofilms, even in multidrug-resistant strains. This host defence peptide shows promise as a new therapeutic agent against persistent bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Staphylococcus epidermidis is a primary cause of hospital-acquired infections, forming antibiotic-resistant biofilms on medical devices.
- Biofilms are bacterial communities encased in an extracellular matrix, exhibiting significantly higher antibiotic resistance than planktonic bacteria.
- Host defence peptides (HDPs) are promising candidates for novel antibiotic development due to their potent antimicrobial properties.
Purpose of the Study:
- To investigate the antibiofilm activity of a short variant of chicken cathelicidin-2, peptide F(2,5,12)W, against Staphylococcus epidermidis.
- To evaluate the efficacy of peptide F(2,5,12)W in preventing biofilm formation and impairing mature biofilms of both wild-type and multidrug-resistant S. epidermidis strains.
Main Methods:
- In vitro assessment of peptide F(2,5,12)W's antibiofilm activity against two S. epidermidis strains.
- Determination of biofilm inhibition and disruption capabilities at various peptide concentrations.
- Measurement of biofilm metabolic activity following peptide challenge.
Main Results:
- Peptide F(2,5,12)W potently inhibited S. epidermidis biofilm formation at 2.5 μM, a concentration below its minimal inhibitory concentration (10 μM).
- Pre-formed biofilms were impaired by peptide F(2,5,12)W; a 4-hour challenge with 40 μM F(2,5,12)W eradicated metabolic activity in wild-type biofilms and reduced it by over 50% in multidrug-resistant biofilms.
- The peptide demonstrated significant antibiofilm activity against both tested strains, including a multidrug-resistant isolate.
Conclusions:
- Peptide F(2,5,12)W is effective in preventing the formation of Staphylococcus epidermidis biofilms.
- The peptide also demonstrates the ability to impair established S. epidermidis biofilms, offering a dual-action therapeutic potential.
- F(2,5,12)W represents a promising candidate for developing new strategies against nosocomial infections caused by S. epidermidis biofilms.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Biofilms
Staphylococcal Skin Infections
Inhibitors of Gram-positive Cell Wall Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
